Product Program year 2025 Source: CMS Open Payments

Introcan Safety

Device Vascular Access

PDI 04046963185206

Open in the dashboard

General payments

$58,295

73 payments

Research payments

$355,899

7 payments

Through program year 2025, $58,295 in general payments and $355,899 in research payments were reported against Introcan Safety (Vascular Access).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $28,983 27
2025 Research $213,450 3
2024 General $8,454 28
2023 General $7,552 8
2022 General $4,168 6
2022 Research $25,000 1
2021 General $9,138 4
2021 Research $117,448 3

Breakdown

Who paid General payments · program years 2021–2025
  1. B. Braun Medical Inc. $58,295 73 payments
Top recipients General payments · program year 2025
  1. John Ledonne Surgery · Baltimore, MD $10,380 36% · 7 payments
  2. Obinna Uzodinma Anesthesiology · Dallas, TX $8,014 28% · 6 payments
  3. Ucsf Medical Center Teaching hospital · CA $5,000 17% · 2 payments
  4. Kimmerle Pawar Emergency Medicine · Boca Raton, FL $4,717 16% · 7 payments
  5. Lauren Daman Dermatology · Hartford, CT $223 <1% · 1 payment

The top 5 of 9 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Surgery $10,380 43% · 1 practitioner
  2. Anesthesiology $8,014 33% · 1 practitioner
  3. Emergency Medicine $4,757 20% · 2 practitioners
  4. Nurse Practitioner, Acute Care Nurse Practitioner $223 <1% · 1 practitioner
  5. Dermatology $223 <1% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $10,380 36% · 1 recipient
  2. Texas $8,014 28% · 1 recipient
  3. California $5,000 17% · 1 recipient
  4. Florida $4,717 16% · 1 recipient
  5. Louisiana $223 <1% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

73 general · 7 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record